Use of a Novel Thyroid-Stimulating Hormone Model for Predicting the Progression of Hepatocellular Carcinoma.
Lihua YuXiaoli LiuYuyong JiangXinhui WangXianbo WangZhi-Yun YangPublished in: OncoTargets and therapy (2020)
The prognostic model of HCC progression was superior to other well-known classical tumor scoring systems. A high TSH level was correlated to poor outcome, particularly those with advanced HCC.
Keyphrases